Steven G. Deeks, MD, is a Professor of Medicine at the University of California, San Francisco. He is an expert on HIV and its impact on health during antiretroviral therapy. Dr. Deeks is the principal investigator the Delaney AIDS Research Enterprise (DARE), an NIH-funded international collaboratory aimed at developing a cure for HIV infection. He directs the SCOPE research program, which has supported hundreds of collaborative studies globally and over 20 investigator-initiated clinical trials. In early 2020 his team leveraged the SCOPE program to implement LIINC, one of the first prospective studies aimed at defining the natural history, biology and treatment of Long COVID. He has published over 800 peer-reviewed articles. Dr. Deeks was elected to the American Society for Clinical Investigation (ASCI) and the Association of America Physicians (AAP) and serves on the scientific advisory board for Science Translational Medicine. In 2022, he received the UCSF Lifetime Achievement in Mentoring Award. He maintains a primary care clinic for people living with HIV.